Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 162,169 | 139,924 | 152,981 | 114,472 | 196,676 |
| Operating Income | -162,169 | -139,924 | -152,981 | -114,472 | -196,676 |
| Other Income | 25,089 | 36,800 | 24,278 | 19,452 | 15,875 |
| Pre-tax Income | -137,080 | -103,124 | -128,703 | -95,020 | -180,801 |
| Net Income Continuous | -137,080 | -103,124 | -128,703 | -95,020 | -180,801 |
| Net Income | $-137,080 | $-103,124 | $-128,703 | $-95,020 | $-180,801 |
| EPS Basic Total Ops | -1.02 | -0.83 | -1.10 | -0.85 | -1.83 |
| EPS Basic Continuous Ops | -1.02 | -0.83 | -1.10 | -0.85 | -1.83 |
| EPS Diluted Total Ops | -1.02 | -0.83 | -1.10 | -0.85 | -1.83 |
| EPS Diluted Continuous Ops | -1.02 | -0.83 | -1.10 | -0.85 | -1.83 |
| EPS Diluted Before Non-Recurring Items | -1.02 | -0.83 | -1.10 | N/A | N/A |
| EBITDA(a) | $-169,060 | $-141,536 | $-159,437 | $-122,372 | $-196,097 |